Suscríbete al boletín semanal

Recibe cada semana los contenidos más relevantes de la actualidad científica.

Agencia Sinc
Si estás registrado

No podrás conectarte si excedes diez intentos fallidos.

Si todavía no estás registrado

La Agencia SINC ofrece servicios diferentes dependiendo de tu perfil.

Selecciona el tuyo:

Periodistas Instituciones

Un estudio analiza la calidad de vida de cuidadores y pacientes de esquizofrenia

Fuente: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 15(4): 286-295, noviembre de 2011; DOI: 10.3109/13651501.2011.608469.
Primer autor: María Fe Bravo-Ortiz.
Centro: Universidad Autónoma de Madrid.

Más información sobre:
esquizofrenia
pacientes
cuidadores
calidad de vida

SINC | 10 noviembre 2011 13:54

Title: Influence of type of treatment on the well-being of Spanish patients with schizophrenia and their caregivers.

Abstract: Objective. This study aimed to investigate quality of life and burden on caregivers in Spanish outpatients with schizophrenia, treated with different antipsychotics. Methods. Sociodemographic and clinical data were collected for 1865 patients diagnosed with schizophrenia. Patients answered the EuroQol-5D questionnaire and caregivers answered questionnaires assessing caregiver burden. Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression of Severity (CGI-S), and clinician's satisfaction were also recorded. The same data were also collected at months 3 and 6. Results. According to EQ-5D results, usual activities (29.6%) and anxiety/depression (31.1%) were the most relevant reported problems. Good overall scores (5-7) on EQ-5D were reported by 47/118 (39.8%) of risperidone long-acting injectable (LAI) patients compared to 52/218 (23.9%) for oral conventional antipsychotics, 51/194 (26.2%) for injectable conventional antipsychotics, and 332/1110 (29.9%) for oral atypical antipsychotics. Significant benefits of risperidone LAI vs. other types of antipsychotic were also found in caregiver burden and clinician-derived outcome measures. At months 3 and 6, retention was >85%, and score on the EQ5D improved for the overall sample. Conclusions. In Spanish patients with schizophrenia, activities of daily living and anxiety/depression were more relevant reported problems. Risperidone LAI was associated with better quality-of-life outcomes and lower caregiver burden compared to other types of antipsychotic.

Author(s): Bravo-Ortiz, MF (Fe Bravo-Ortiz, Maria)1; Gutierrez-Casares, JR (Ramon Gutierrez-Casares, Jose); Rodriguez-Morales, A (Rodriguez-Morales, Alexander)2; Garcia, MAP (Pena Garcia, Mario Alberto)2; Hidalgo-Borrajo, R (Hidalgo-Borrajo, Rebeca)3

Addresses:

1. Univ Autonoma Madrid, Hosp Univ La Paz, Dept Psychiat, E-28049 Madrid, Spain

2. Med Affairs Dept, Janssen Cilag, Spain

3. Ctr Salud Mental Infanto Juvenil Natividad Zubiet, Pamplona, Spain

Si eres periodista y quieres el contacto con los investigadores, regístrate en SINC como periodista.

Zona geográfica: Comunidad de Madrid
Fuente: SINC

Comentarios

Queremos saber tu opinión